Oncology Archives

Poster

Paired DNA and RNA genetic testing improves variant detection and classification independently of personal history of cancer

Date:

Monday, Oct 18, 2021 12:00am – 12:00pm

Conference:

ASHG 2021

Authors:

Sarah Campian, Rachid Karam, PhD, Elizabeth Chao, Carrie Horton, Kelly Burgess, Jessica Profato, Robert Pilarski, Holly Laduca, Parichehr Hemyari, Heather Zimmerman

Poster

Closing the gap: Trends in inconclusive rates in hereditary cancer testing across racial/ethnic groups

Oncology

Session:

#10525

Date:

Friday, Jun 4, 2021 12:00am – 12:00pm

Conference:

ASCO 2021

Authors:

Carrie Horton, Holly Laduca, Timothy Komala, Jessica Profato, Tina Pesaran, MA, MS, CGC, Fergus Couch, Foluso Olabisi Ademuyiwa

Collaborators:

Mayo Clinic

Washington University School of Medicine, St. Louis Children’s Hospital

Abstract Poster

Poster

Multi-gene panel testing results prompt frequent and guideline adherent changes to cancer risk management recommendations based on clinician report

General

Oncology

Date:

Tuesday, Apr 13, 2021 12:00am – 12:00pm

Conference:

ACMG 2021

Authors:

Holly Laduca, Virginia Speare, Allison Kurian, Carolyn Horton, Kristen Blanco, Min-Tzu Lo, Jill Dolinksy

Poster Abstract

Presentation

The uniform application of protein functional data has an impressive potential to resolve VUS rates in BRCA2

Oncology

Speakers:

Marcy Richardson, Chunling Hu, Kun Y. Lee, Holly LaDuca, Kelly Fulk, Kate M. Durda, Ashley M. Deckman, David E. Goldgar, Rohan Gnanaolivu, Steven N. Hart, Eric C. Polley, Elizabeth Chao, Tina Pesaran, Fergus J. Couch

Conference:

ACMG 2021

Tuesday, Apr 13, 2021 12:00am – 12:00pm

Collaborators:

Mayo Clinic

University of Utah

Abstract

Poster

Divergent payor medical policy leads to gross disparities in access to hereditary breast and ovarian cancer genetic testing

Oncology

Date:

Tuesday, Apr 13, 2021 12:00am – 12:00pm

Conference:

ACMG 2021

Authors:

Robert Pilarski, Stephanie Gutierrez, Stephanie Gandomi, Holly Laduca, Lily Hoang, Randy Hew, Jill Dolinksy

Abstract Poster

Presentation

Pathogenic duplications in tumor suppressor genes cause aberrant mRNA splicing

Oncology

Speakers:

Blair R. Conner, Marcy Richardson, Terra Brannan, Felicia Hernandez, Noriko Yokoyama, Tyler Landrith, Tamara McBride, Tina Pesaran, Rachid Karam

Conference:

ACMG 2021

Tuesday, Apr 13, 2021 12:00am – 12:00pm

Abstract

Presentation

Implementation of routine genetic screening in a rural gastrointestinal clinic leads to the identification of inherited gastrointestinal disorders and other cancer risks in 20% of patients tested

Oncology

Speakers:

Howard P. Monsour, Carrie Milliard, Frederick Oriti, Cynthia Wade, Nicole Jennings, Michelle Stegenga, Linda L. Heflin, Paul Schmidt, Megan Week, Russell Peterson, Rachel Bluebond, Lily Hoang, Holly Laduca

Conference:

DDW 2022

Friday, May 21, 2021 12:00pm – 12:00pm

Abstract

Presentation

Mutation spectrum and rates of variants of uncertain significance among African American males undergoing prostate cancer germline testing: Need for equity in genetic testing

Oncology

Speakers:

Veda N. Giri, Rebecca Hartman, Mary Pritzlaff, Scott Keith

Conference:

ASCO 2022

Friday, Jun 3, 2022 12:00pm – 12:00pm

Abstract

Poster

Double jeopardy? A closer look at cancer histories of individuals with multiple germline pathogenic variants

Oncology

Session:

#10514

Date:

Friday, Jun 3, 2022 12:00pm – 12:00am

Conference:

ASCO 2022

Authors:

Amal Yussuf, Cassidy Carraway, Huma Rana, Carolyn Horton, Min-Tzu Lo, Colin C. Young, Nihat Agaoglu, Brittany L. Bychkovsky

Poster

Presentation

Germline genetic testing use and results after a cancer diagnosis

Oncology

Session:

#10500

Speakers:

Allison W. Kurian, Paul Abrahamse, Allison Kate Cullen Furgal, Kevin C. Ward, Ann S. Hamilton, Rachel Hodan, Lihua Liu, Jonathan S. Berek, Lily Hoang, Amal Yussuf, Lisa R. Susswein, Edward D. Esplin, Thomas Paul Slavin, Scarlett L. Gomez, Timothy Hofer, Steven Katz

Conference:

ASCO 2023

Monday, Jun 5, 2023 3:00pm – 6:00pm

Oncology

Paired DNA and RNA genetic testing improves variant detection and classification independently of personal history of cancer

Closing the gap: Trends in inconclusive rates in hereditary cancer testing across racial/ethnic groups

Multi-gene panel testing results prompt frequent and guideline adherent changes to cancer risk management recommendations based on clinician report

The uniform application of protein functional data has an impressive potential to resolve VUS rates in BRCA2

Divergent payor medical policy leads to gross disparities in access to hereditary breast and ovarian cancer genetic testing

Pathogenic duplications in tumor suppressor genes cause aberrant mRNA splicing

Implementation of routine genetic screening in a rural gastrointestinal clinic leads to the identification of inherited gastrointestinal disorders and other cancer risks in 20% of patients tested

Mutation spectrum and rates of variants of uncertain significance among African American males undergoing prostate cancer germline testing: Need for equity in genetic testing

Double jeopardy? A closer look at cancer histories of individuals with multiple germline pathogenic variants

Germline genetic testing use and results after a cancer diagnosis

Patients

PROVIDERS

Solutions

Resources

Company

NOTICES

Oncology

Get in Touch